Susquehanna International Group’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $286K | Buy |
14,601
+6,468
| +80% | +$158K | ﹤0.01% | 10964 |
|
|
2025
Q4 | $218K | Buy |
+8,133
| New | +$209K | ﹤0.01% | 10699 |
|
|
2025
Q3 | – | Sell |
-54,598
| Closed | -$1.25M | – | 12291 |
|
|
2025
Q2 | $1.25M | Sell |
54,598
-16,111
| -23% | -$400K | ﹤0.01% | 6865 |
|
|
2025
Q1 | $2.05M | Buy |
70,709
+39,443
| +126% | +$1.26M | ﹤0.01% | 5480 |
|
|
2024
Q4 | $1.16M | Buy |
31,266
+16,483
| +111% | +$754K | ﹤0.01% | 6591 |
|
|
2024
Q3 | $717K | Sell |
14,783
-2,910
| -16% | -$128K | ﹤0.01% | 7586 |
|
|
2024
Q2 | $708K | Sell |
17,693
-3,715
| -17% | -$154K | ﹤0.01% | 7386 |
|
|
2024
Q1 | $940K | Sell |
21,408
-5,757
| -21% | -$297K | ﹤0.01% | 7067 |
|
|
2023
Q4 | $1.68M | Sell |
27,165
-2,160
| -7% | -$113K | ﹤0.01% | 5733 |
|
|
2023
Q3 | $1.35M | Sell |
29,325
-5,612
| -16% | -$306K | ﹤0.01% | 5956 |
|
|
2023
Q2 | $2.01M | Sell |
34,937
-7,440
| -18% | -$330K | ﹤0.01% | 5152 |
|
|
2023
Q1 | $1.59M | Buy |
+42,377
| New | +$1.39M | ﹤0.01% | 5668 |
|
|
2022
Q4 | – | Sell |
-12,368
| Closed | -$359K | – | 12314 |
|
|
2022
Q3 | $348K | Sell |
12,368
-4,213
| -25% | -$138K | ﹤0.01% | 9413 |
|
|
2022
Q2 | $577K | Sell |
16,581
-39,001
| -70% | -$1.39M | ﹤0.01% | 7900 |
|
|
2022
Q1 | $2M | Buy |
+55,582
| New | +$1.58M | ﹤0.01% | 5487 |
|
|
2021
Q2 | – | Sell |
-14,574
| Closed | -$267K | – | 12502 |
|
|
2021
Q1 | $267K | Buy |
14,574
+4,557
| +45% | +$84.7K | ﹤0.01% | 10841 |
|
|
2020
Q4 | $201K | Sell |
10,017
-24,860
| -71% | -$484K | ﹤0.01% | 10026 |
|
|
2020
Q3 | $654K | Buy |
34,877
+12,743
| +58% | +$257K | ﹤0.01% | 7107 |
|
|
2020
Q2 | $497K | Buy |
22,134
+1,476
| +7% | +$27K | ﹤0.01% | 7370 |
|
|
2020
Q1 | $307K | Buy |
20,658
+6,825
| +49% | +$119K | ﹤0.01% | 7923 |
|
|
2019
Q4 | $267K | Sell |
13,833
-14,908
| -52% | -$286K | ﹤0.01% | 8234 |
|
|
2019
Q3 | $570K | Sell |
28,741
-18,946
| -40% | -$395K | ﹤0.01% | 6994 |
|
|
2019
Q2 | $1.01M | Buy |
+47,687
| New | +$997K | ﹤0.01% | 5644 |
|
|
2018
Q3 | – | Sell |
-12,795
| Closed | -$195K | – | 9137 |
|
|
2018
Q2 | $195K | Buy |
+12,795
| New | +$224K | ﹤0.01% | 8629 |
|
|
2017
Q1 | – | Sell |
-93,823
| Closed | -$1.48M | – | 8864 |
|
|
2016
Q4 | $1.73M | Buy |
+93,823
| New | +$1.83M | ﹤0.01% | 4377 |
|
|
2016
Q1 | – | Sell |
-36,677
| Closed | -$522K | – | 8949 |
|
|
2015
Q4 | $522K | Sell |
36,677
-36
| -0.1% | -$476 | ﹤0.01% | 6684 |
|
|
2015
Q3 | $430K | Sell |
36,713
-374
| -1% | -$5.61K | ﹤0.01% | 7401 |
|
|
2015
Q2 | $652K | Buy |
+37,087
| New | +$578K | ﹤0.01% | 7098 |
|
Other funds holding AMPH
VCM
BTW
Susquehanna International Group's AMPH Position: Q1 2026 in Review
Susquehanna International Group increased its Amphastar Pharmaceuticals (AMPH) stake by 80% in Q1 2026, buying an estimated $158K and bringing the position to 14,601 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #10964.
Susquehanna International Group first reported a position in AMPH in Q2 2015 and has held it in 28 quarters since. The position peaked at $2.05M in Q1 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Susquehanna International Group held 14,601 shares of Amphastar Pharmaceuticals worth $286K as of Q1 2026.
- Susquehanna International Group bought 6,468 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $158K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10964 holding.
- Susquehanna International Group first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 28 quarters since.
- Susquehanna International Group's Amphastar Pharmaceuticals position peaked at $2.05M in Q1 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.